A CCR5 antagonist-based HIV entry inhibitor exhibited potent spermicidal activity: Potential application for contraception and prevention of HIV sexual transmission. [electronic resource]
- European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences May 2018
- 313-320 p. digital
Publication Type: Journal Article
1879-0720
10.1016/j.ejps.2018.02.026 doi
Administration, Intravaginal Animals CCR5 Receptor Antagonists--administration & dosage Dose-Response Relationship, Drug Female Gels HIV Fusion Inhibitors--administration & dosage HIV Infections--prevention & control Humans Male Piperazines--administration & dosage Pregnancy Pregnancy Rate Rabbits Receptors, CCR5--drug effects Sperm Motility--drug effects Sperm-Ovum Interactions--drug effects Spermatocidal Agents--administration & dosage Spermatozoa--drug effects Time Factors